TLS/FUS-ERG fusion gene in acute lymphoblastic leukemia with t(16;21)(p11;q22) and monitoring of minimal residual disease

Leukemia and Lymphoma

Volumn 46, Issue 12, 2005, Pages 1833-1835

  Kanazawa, Takashi ^a   Ogawa, Chitose ^a   Taketani, Takeshi ^d   Taki, Tomohiko ^b   Hayashi, Yasuhide ^c   Morikawa, Akihiro ^a  

^a GUNMA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b SHIMANE UNIVERSITY FACULTY OF MEDICINE   (Japan)

^c KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^d Gumna Children S Medical Center   (Japan)

Author keywords

Acute lymphoblastic leukemia; Acute myeloid leukemia; Minimal residual disease; TLS FUS, ERG, t(16; 21)(p11; q22)

Indexed keywords

ASPARAGINASE; BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN; CYTARABINE; ETOPOSIDE; IDARUBICIN; MESSENGER RNA; METHOTREXATE; PIRARUBICIN; PREDNISOLONE; PROTEIN FUS; PROTEIN TLS; RNA BINDING PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR ERG; UNCLASSIFIED DRUG; VINCRISTINE;

ACUTE GRAFT VERSUS HOST DISEASE; ACUTE LYMPHOBLASTIC LEUKEMIA; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; B CELL LEUKEMIA; CASE REPORT; CHIMERA; CHRONIC GRAFT VERSUS HOST DISEASE; DRUG RESPONSE; EXON; FUSION GENE; GENE SEQUENCE; GENETIC TRANSCRIPTION; HUMAN; KARYOTYPE 46,XY; LEUKEMIA REMISSION; MALE; MINIMAL RESIDUAL DISEASE; PATIENT MONITORING; PRESCHOOL CHILD; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BASE SEQUENCE; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 16; CHROMOSOMES, HUMAN, PAIR 21; CYTARABINE; ETOPOSIDE; EXONS; HUMANS; IDARUBICIN; INFANT; LEUKEMIA, LYMPHOCYTIC, ACUTE; MALE; NEOPLASM, RESIDUAL; ONCOGENE PROTEINS, FUSION; RNA-BINDING PROTEIN FUS; TRANSLOCATION, GENETIC; TREATMENT OUTCOME;

EID: 32144431577     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.1080/10428190500162203     Document Type: Article

References (8)

1. Ichikawa, H and Shimizu, K and Hayashi, Y and Ohki, M. (1994) An RNA-binding protein gene, TLS/FUS, is fused to ERG in human myeloid leukemia with t(16;21) chromosomal translocation Cancer Res, 54, pp. 2865 - 2768.
2. Kong, X and Ida, K and Ichikawa, H and Shimizu, K and Ohki, M and Maseki, N and (1997) Consistent detection of TLS/FUS-ERG chimeric transcripts in acute myeloid leukemia with t(16;21)(p11;q22) and identification of a novel transcript Blood, 90, pp. 1192 - 1199.
3. Shing, D and McMullan, D and Roberts, P and Smith, K and Chin, S and Nicholson, J and (2003) FUS/ERG gene fusions in Ewing's tumors Cancer Res, 63, pp. 4568 - 4576.
4. Okoshi, Y and Shimizu, S and Kojima, H and Obara, N and Mukai, H and Komeno, T and (2001) Detection of minimal residual disease in a patient having acute myelogenous leukemia with t(16;21)(p11;q22) treated by allogeneic bone marrow transplantation Acta Haematol, 105, pp. 45 - 48.
5. Shimizu, K and Ichikawa, H and Tojo, A and Kaneko, Y and Maseki, N and Hayashi, Y and (1993) An ets-related gene, ERG, is rearranged in human myeloid leukemia with t(16;21) chromosomal translocation Proc Natl Acad Sci USA, 90, pp. 10280 - 10284.
6. Panagopoulos, I and Aman, P and Fioretos, T and Hoglund, M and Johansson, B and Mandahl, N and (1994) Fusion of the FUS gene with ERG in acute myeloid leukemia with t(16;21)(p11;q22) Genes Chromosomes Cancer, 11, pp. 256 - 262.
7. Pereira, D and Dorrell, C and Ito, C and Gan, O and Murdoch, B and Rao, V and (1997) Retroviral transduction of TLS-ERG initiates a leukemogenic program in normal human hematopoietic cells Oncogene, 15, pp. 1357 - 1362.
8. Hicks, G and Singh, N and Nashabi, A and Mai, S and Bozek, G and Klewes, L and (2000) Fus deficiency in mice results in defective B-lymphocyte development and activation, high levels of chromosomal instability and perinatal death Nat Genet, 24, pp. 175 - 179. 8